These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 663408)

  • 1. The effects of cannabinoids on body temperature and brain catecholamine synthesis.
    Bloom AS; Johnson KM; Dewey WL
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):51-7. PubMed ID: 663408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of delta9-tetrahydrocannabinol, cannabinol and cannabidiol on tissue oxygen consumption.
    Chiu P; Karler R; Craven C; Olsen DM; Turkanis SA
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):267-86. PubMed ID: 1197914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of delta9-tetrahydrocannabinol on the synthesis of dopamine and norepinephrine in mouse brain synaptosomes.
    Bloom AS
    J Pharmacol Exp Ther; 1982 Apr; 221(1):97-103. PubMed ID: 6278139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.
    Tripathi HL; Vocci FJ; Brase DA; Dewey WL
    Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of ambient temperature with the effects of delta 9-tetrahydrocannabinol on brain catecholamine synthesis and plasma corticosterone levels.
    Bloom AS; Kiernan CJ
    Psychopharmacology (Berl); 1980; 67(3):215-9. PubMed ID: 6247738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9-nor-9beta-hydroxyhexahydrocannabinol, a cannabinoid with potent antinociceptive activity: comparisons with morphine.
    Bloom AS; Dewey WL; Harris LS; Brosius KK
    J Pharmacol Exp Ther; 1977 Feb; 200(2):263-70. PubMed ID: 839438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cannabinoids on L1210 murine leukemia. 1. Inhibition of DNA synthesis.
    Tucker AN; Friedman MA
    Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):703-14. PubMed ID: 897352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine-C14 in brain.
    Nybäck H; Sedvall G
    J Pharmacol Exp Ther; 1968 Aug; 162(2):294-301. PubMed ID: 5666984
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.
    Hillard CJ; Harris RA; Bloom AS
    J Pharmacol Exp Ther; 1985 Mar; 232(3):579-88. PubMed ID: 2983062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavioral effects of cannabis extract in rat: role of catecholamines].
    Arrigo Reina R; Scoto GM; Spadaro C; Mazzone G
    Boll Soc Ital Biol Sper; 1978 Dec; 54(23):2348-54. PubMed ID: 574388
    [No Abstract]   [Full Text] [Related]  

  • 11. Structure-activity relationships of indole- and pyrrole-derived cannabinoids.
    Wiley JL; Compton DR; Dai D; Lainton JA; Phillips M; Huffman JW; Martin BR
    J Pharmacol Exp Ther; 1998 Jun; 285(3):995-1004. PubMed ID: 9618400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
    Reichman M; Nen W; Hokin LE
    Mol Pharmacol; 1988 Dec; 34(6):823-8. PubMed ID: 2849049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine hypothermia and brain nicotine and catecholamine levels in the mouse.
    Mansner R; Alhava E; Klinge E
    Med Biol; 1974 Dec; 52(6):390-8. PubMed ID: 4444360
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.
    Poddar MK; Dewey WL
    J Pharmacol Exp Ther; 1980 Jul; 214(1):63-7. PubMed ID: 7391971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Testing the pharmacological activity of some synthetic cannabinoids in mice (author's transl)].
    Ganz AJ; Waser PG
    Arzneimittelforschung; 1980; 30(3):471-7. PubMed ID: 7387758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
    Lastres-Becker I; Molina-Holgado F; Ramos JA; Mechoulam R; Fernández-Ruiz J
    Neurobiol Dis; 2005; 19(1-2):96-107. PubMed ID: 15837565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid effects on plasma corticosterone and uptake of 3H-corticosterone by mouse brain.
    Johnson KM; Dewey WL; Ritter KS; Beckner JS
    Eur J Pharmacol; 1978 Feb; 47(3):303-10. PubMed ID: 631183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.
    Shook JE; Burks TF
    J Pharmacol Exp Ther; 1989 May; 249(2):444-9. PubMed ID: 2542532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.
    Little PJ; Compton DR; Johnson MR; Melvin LS; Martin BR
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1046-51. PubMed ID: 2849657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.